Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey Seow

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Marine Drugs|February 24, 2023
Characterisation of Elevenin-Vc1 from the Venom of <i>Conus victoriae</i>: A Structural Analogue of α-ConotoxinsBankala Krishnarjuna, Punnepalli Sunanda, Jeffrey Seow, et al.
Vaccines|August 28, 2021
Guiding the Immune Response to a Conserved Epitope in MSP2, an Intrinsically Disordered Malaria Vaccine CandidateJeffrey Seow, Sreedam C Das, Rodrigo A V Morales, et al.
Cell Reports|August 18, 2022
A neutralizing epitope on the SD1 domain of SARS-CoV-2 spike targeted following infection and vaccinationJeffrey Seow, Hataf Khan, Annachiara Rosa, et al.
Mbio|March 17, 2022
Broad Neutralization of SARS-CoV-2 Variants, Including Omicron, following Breakthrough Infection with Delta in COVID-19-Vaccinated IndividualsThomas Lechmere, Luke B Snell, Carl Graham, et al.
Vaccine|February 23, 2021
Liposome engraftment and antigen combination potentiate the immune response towards conserved epitopes of the malaria vaccine candidate MSP2Sreedam C Das, Jason D Price, Katharine Gosling, et al.
Vaccines|February 26, 2025
Long-Term Immune Consequences of Initial SARS-CoV-2 A.23.1 Exposure: A Longitudinal Study of Antibody Responses and Cross-Neutralization in a Ugandan CohortGerald Kevin Oluka, Jackson Sembera, Joseph Ssebwana Katende, et al.
Nature Medicine|August 20, 2020
Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infectionMichael J Carter, Matthew Fish, Aislinn Jennings, et al.
Elife|December 22, 2020
Molecular rationale for antibody-mediated targeting of the hantavirus fusion glycoproteinIlona Rissanen, Robert Stass, Stefanie A Krumm, et al.
Mbio|September 25, 2023
Broad and potent neutralizing antibodies are elicited in vaccinated individuals following Delta/BA.1 breakthrough infectionJeffrey Seow, Zayed A Shalim, Carl Graham, et al.
Vaccines|May 7, 2025
Geographical Differences in SARS-CoV-2 Antibody Response Dynamics and Neutralisation Profiles to Mild COVID-19: Lessons from a UK-Uganda ComparisonLaban Kato, Jackson Sembera, Gerald Kevin Oluka, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Marine Drugs|February 24, 2023
Characterisation of Elevenin-Vc1 from the Venom of <i>Conus victoriae</i>: A Structural Analogue of α-ConotoxinsBankala Krishnarjuna, Punnepalli Sunanda, Jeffrey Seow, et al.
Vaccines|August 28, 2021
Guiding the Immune Response to a Conserved Epitope in MSP2, an Intrinsically Disordered Malaria Vaccine CandidateJeffrey Seow, Sreedam C Das, Rodrigo A V Morales, et al.
Cell Reports|August 18, 2022
A neutralizing epitope on the SD1 domain of SARS-CoV-2 spike targeted following infection and vaccinationJeffrey Seow, Hataf Khan, Annachiara Rosa, et al.
Mbio|March 17, 2022
Broad Neutralization of SARS-CoV-2 Variants, Including Omicron, following Breakthrough Infection with Delta in COVID-19-Vaccinated IndividualsThomas Lechmere, Luke B Snell, Carl Graham, et al.
Vaccine|February 23, 2021
Liposome engraftment and antigen combination potentiate the immune response towards conserved epitopes of the malaria vaccine candidate MSP2Sreedam C Das, Jason D Price, Katharine Gosling, et al.
Vaccines|February 26, 2025
Long-Term Immune Consequences of Initial SARS-CoV-2 A.23.1 Exposure: A Longitudinal Study of Antibody Responses and Cross-Neutralization in a Ugandan CohortGerald Kevin Oluka, Jackson Sembera, Joseph Ssebwana Katende, et al.
Nature Medicine|August 20, 2020
Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infectionMichael J Carter, Matthew Fish, Aislinn Jennings, et al.
Elife|December 22, 2020
Molecular rationale for antibody-mediated targeting of the hantavirus fusion glycoproteinIlona Rissanen, Robert Stass, Stefanie A Krumm, et al.
Mbio|September 25, 2023
Broad and potent neutralizing antibodies are elicited in vaccinated individuals following Delta/BA.1 breakthrough infectionJeffrey Seow, Zayed A Shalim, Carl Graham, et al.
Vaccines|May 7, 2025
Geographical Differences in SARS-CoV-2 Antibody Response Dynamics and Neutralisation Profiles to Mild COVID-19: Lessons from a UK-Uganda ComparisonLaban Kato, Jackson Sembera, Gerald Kevin Oluka, et al.
Pageof 5